Sanofi SA (France) Today

SAN Stock  EUR 91.76  0.46  0.50%   

Performance

3 of 100

 
Low
 
High
Insignificant

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Sanofi SA is trading at 91.76 as of the 28th of March 2024, a 0.50 percent up since the beginning of the trading day. The stock's open price was 91.3. Sanofi SA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Sanofi SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was incorporated in 1994 and is headquartered in Paris, France. SANOFI operates under Drug ManufacturersGeneral classification in France and is traded on Paris Stock Exchange. The company has 1.25 B outstanding shares. More on Sanofi SA

Moving together with Sanofi Stock

  0.66BNP BNP Paribas SAPairCorr
  0.67ACA Credit Agricole SAPairCorr

Moving against Sanofi Stock

  0.64ALRIB Riber SAPairCorr
  0.6ALSEN Sensorion SAPairCorr
  0.57GNE General ElectricPairCorr
  0.54VIV Vivendi SAPairCorr
  0.44RNO Renault SAPairCorr
  0.42CS AXA SAPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Sanofi Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sanofi SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sanofi SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationDrug Manufacturers—General, Healthcare (View all Sectors)
Sanofi SA (SAN) is traded on Euronext Paris in France and employs 91,573 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 110.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sanofi SA's market, we take the total number of its shares issued and multiply it by Sanofi SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sanofi SA operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.25 B outstanding shares. Sanofi SA has accumulated about 9.72 B in cash with 10.53 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.76.
Check Sanofi SA Probability Of Bankruptcy
Ownership Allocation
Sanofi SA maintains a total of 1.25 Billion outstanding shares. 30% of Sanofi SA outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Sanofi Ownership Details

Sanofi Stock Price Odds Analysis

What are Sanofi SA's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Sanofi SA jumping above the current price in 90 days from now is about 26.33%. The Sanofi SA probability density function shows the probability of Sanofi SA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Sanofi SA has a beta of 0.1053. This usually implies as returns on the market go up, Sanofi SA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sanofi SA will be expected to be much smaller as well. Additionally, sanofi SA has an alpha of 0.022, implying that it can generate a 0.022 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 91.76HorizonTargetOdds Above 91.76
73.39%90 days
 91.76 
26.33%
Based on a normal probability distribution, the odds of Sanofi SA to move above the current price in 90 days from now is about 26.33 (This Sanofi SA probability density function shows the probability of Sanofi Stock to fall within a particular range of prices over 90 days) .

Sanofi SA Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sanofi SA market risk premium is the additional return an investor will receive from holding Sanofi SA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sanofi SA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Sanofi SA's alpha and beta are two of the key measurements used to evaluate Sanofi SA's performance over the market, the standard measures of volatility play an important role as well.

Sanofi Stock Against Markets

Picking the right benchmark for Sanofi SA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sanofi SA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sanofi SA is critical whether you are bullish or bearish towards Sanofi SA at a given time. Please also check how Sanofi SA's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sanofi SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Sanofi SA Corporate Management

Elected by the shareholders, the Sanofi SA's board of directors comprises two types of representatives: Sanofi SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sanofi. The board's role is to monitor Sanofi SA's management team and ensure that shareholders' interests are well served. Sanofi SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sanofi SA's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Sanofi Stock?

Before investing in Sanofi SA, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sanofi SA. To buy Sanofi SA stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sanofi SA. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Sanofi SA stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Sanofi SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Sanofi SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sanofi SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Sanofi SA?

The danger of trading Sanofi SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sanofi SA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sanofi SA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sanofi SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Sanofi Stock analysis

When running Sanofi SA's price analysis, check to measure Sanofi SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi SA is operating at the current time. Most of Sanofi SA's value examination focuses on studying past and present price action to predict the probability of Sanofi SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi SA's price. Additionally, you may evaluate how the addition of Sanofi SA to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Please note, there is a significant difference between Sanofi SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.